Exelon Patch
E494103
Exelon Patch is a transdermal medication used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Exelon Patch canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5114881 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Exelon Patch Context triple: [rivastigmine, hasBrandName, Exelon Patch]
-
A.
The Battery
The Battery is a historic defensive seawall and promenade in Charleston, South Carolina, famed for its antebellum homes and views of Charleston Harbor and Fort Sumter.
-
B.
The Battery
The Battery is a historic waterfront park at the southern tip of Manhattan in New York City, known for its harbor views, ferries to the Statue of Liberty and Ellis Island, and landmark Castle Clinton.
-
C.
Versonnex
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
D.
Efficeon
Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
-
E.
Novafora
Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Exelon Patch Target entity description: Exelon Patch is a transdermal medication used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's diseases.
-
A.
The Battery
The Battery is a historic waterfront park at the southern tip of Manhattan in New York City, known for its harbor views, ferries to the Statue of Liberty and Ellis Island, and landmark Castle Clinton.
-
B.
The Battery
The Battery is a historic defensive seawall and promenade in Charleston, South Carolina, famed for its antebellum homes and views of Charleston Harbor and Fort Sumter.
-
C.
Versonnex
Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
-
D.
Efficeon
Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
-
E.
Novafora
Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
prescription drug
ⓘ
rivastigmine transdermal system ⓘ transdermal medication ⓘ |
| administrationFrequency | once daily ⓘ |
| applicationSite |
chest
ⓘ
lower back ⓘ upper arm ⓘ upper back ⓘ |
| benefit |
may reduce gastrointestinal side effects compared with oral rivastigmine
ⓘ
provides continuous delivery of rivastigmine over 24 hours ⓘ |
| commonAdverseEffect |
application site itching
ⓘ
application site redness ⓘ decreased appetite ⓘ diarrhea ⓘ dizziness ⓘ headache ⓘ nausea ⓘ vomiting ⓘ weight loss ⓘ |
| contraindication |
known hypersensitivity to rivastigmine
ⓘ
previous allergic reaction to carbamate derivatives ⓘ |
| drugClass | cholinesterase inhibitor ⓘ |
| hasActiveIngredient | rivastigmine ⓘ |
| hasBrandName | Exelon Patch NERFINISHED ⓘ |
| hasDosageForm | transdermal patch ⓘ |
| hasGenericName | rivastigmine transdermal system ⓘ |
| improvesSymptom |
ability to perform daily activities
ⓘ
cognitive function ⓘ memory ⓘ |
| indication |
treatment of mild to moderate dementia associated with Parkinson’s disease
ⓘ
treatment of mild to moderate dementia of the Alzheimer’s type ⓘ |
| marketedBy | Novartis NERFINISHED ⓘ |
| regulatesEnzyme |
acetylcholinesterase
ⓘ
butyrylcholinesterase NERFINISHED ⓘ |
| regulatoryStatus | prescription only ⓘ |
| requires | intact healthy skin for application ⓘ |
| routeOfAdministration | transdermal ⓘ |
| seriousAdverseEffect |
allergic dermatitis
ⓘ
bradycardia ⓘ gastrointestinal bleeding ⓘ syncope ⓘ |
| treats |
mild dementia associated with Alzheimer’s disease
ⓘ
mild dementia associated with Parkinson’s disease ⓘ moderate dementia associated with Alzheimer’s disease ⓘ moderate dementia associated with Parkinson’s disease ⓘ |
| warning |
may cause gastrointestinal adverse reactions
ⓘ
may cause weight loss ⓘ use with caution in patients with active peptic ulcer disease ⓘ use with caution in patients with cardiac conduction conditions ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Exelon Patch Description of subject: Exelon Patch is a transdermal medication used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's diseases.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.